éå»1ã¶æéã«Edwards Lifesciences Corpã«å¯ŸããŠè©äŸ¡ãåºããã¢ããªã¹ã31åã«åºã¥ãããŒã¿ã
仿ãEWã¯15ä»¶ã®ãè²·ããã6ä»¶ã®ãäžç«ïŒããŒã«ãïŒãã0ä»¶ã®ã売ããè©äŸ¡ãç²åŸããŸãããçŽè¿1ã¶æã«ãããEWã®ã¢ããªã¹ãå¹³åç®æšæ ªäŸ¡ã¯99.603ã§ãã
ã¢ããªã¹ãäºæ³ã«ãããšãFY2026Q2ã«çºè¡šãããEPS 0.420ã«ç¶ããEWã®FY2026Q3ã®EPSã¯0.737ã«éããèŠéãã§ããçºè¡šãããå®çžŸå€ãšäºæ³ãæ¯èŒããŠãåçæ§ã®æšç§»ã確èªããŸãããã
åžå Žäºæ³ã¯ USD 0.42 ã§ããããEdwards Lifesciences CorpEW ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD 0.66 ã§ãããæ¬¡ã®ååæã® EPS 㯠USD 0.74 ãšäºæ³ãããŸãã